Swiftmerge Acquisition Corp. (IVCP)
| Previous Close | 10.64 |
| Open | 10.64 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 1100 |
| Day's Range | 10.64 - 10.64 |
| 52 Week Range | 9.84 - 11.85 |
| Volume | |
| Avg. Volume | 14,232 |
| Market Cap | 83.757M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 50.67 |
| EPS (TTM) | 0.21 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Insider MonkeyFarallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks
In this article, we discuss Farallon Capital: a global and diversified hedge fund and its top stock picks. If you want to skip our detailed analysis of these stocks, go directly to the Top 5 Stock Picks of Farallon Capital. Risk arbitrage or merger arbitrage is one of the most popular strategies that hedge funds […]
Business WireHDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp.
NEW YORK & VERO BEACH, Fla., August 11, 2023--HDL Therapeutics, Inc. ("HDL Therapeutics"), a privately held commercial stage biotech company with an FDA-approved cardiovascular therapy the Plasma Delipidation System (PDS-2™ System) for reducing coronary atheroma in patients with homozygous familial hypercholesterolemia (HoFH), has signed a definitive merger agreement with Swiftmerge Acquisition Corp. (NASDAQ: IVCP) ("Swiftmerge"), a special purpose acquisition company with a disruptive consumer
Simply Wall St.Institutional investors own a significant stake of 36% in Swiftmerge Acquisition Corp. (NASDAQ:IVCP)
Key Insights Significantly high institutional ownership implies Swiftmerge Acquisition's stock price is sensitive to...
